Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Baxter
Cerilliant
Dow
US Department of Justice
Julphar
Queensland Health
Argus Health
Harvard Business School

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050630

« Back to Dashboard

NDA 050630 describes PRIMAXIN, which is a drug marketed by Merck and is included in three NDAs. It is available from one supplier. Additional details are available on the PRIMAXIN profile page.

The generic ingredient in PRIMAXIN is cilastatin sodium; imipenem. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cilastatin sodium; imipenem profile page.
Summary for 050630
Tradename:PRIMAXIN
Applicant:Merck
Ingredient:cilastatin sodium; imipenem
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INTRAMUSCULARStrengthEQ 500MG BASE/VIAL;500MG/VIAL
Approval Date:Dec 14, 1990TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;INTRAMUSCULARStrengthEQ 750MG BASE/VIAL;750MG/VIAL
Approval Date:Dec 14, 1990TE:RLD:No

Expired US Patents for NDA 050630

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-001 Dec 14, 1990 ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-002 Dec 14, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
Boehringer Ingelheim
Merck
Moodys
McKinsey
Fuji
Dow
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.